Related by context. All words. (Click for frequent words.) 69 mapatumumab 69 ixabepilone 68 BAY #-# 66 Irinotecan 66 MGd 66 T DM1 66 cediranib 65 Nexavar ® 65 axitinib 65 temsirolimus 65 abiraterone acetate 65 Avastin bevacizumab 65 Imprime PGG 65 Advexin 65 enzastaurin 65 FOLFIRI 65 gemcitabine chemotherapy 65 Gefitinib 65 Traficet EN 64 glufosfamide 64 carfilzomib 64 sorafenib tablets 64 Marqibo 64 Perifosine 64 Amrubicin 64 YONDELIS 64 dasatinib 64 sorafenib Nexavar 64 Vandetanib 64 pertuzumab 64 Fludara 64 cetuximab Erbitux ® 64 PXD# 64 HGS# 64 Targretin 64 vorinostat 64 RSR# 64 CoFactor 64 vandetanib 64 trabectedin 64 CA4P 64 aflibercept 64 CIMZIA TM 64 docetaxel Taxotere ® 64 IMC A# 64 Velcade bortezomib 64 standard chemotherapy regimen 64 bortezomib 63 Jevtana 63 ADVEXIN 63 methylnaltrexone 63 Gemcitabine 63 mTOR inhibitor 63 zalutumumab 63 Aflibercept 63 HuMax EGFr 63 topotecan 63 bevacizumab Avastin 63 MGCD# [001] 63 Azedra 63 decitabine 63 clofarabine 63 Vicinium TM 63 relapsed refractory multiple myeloma 63 metastatic hormone refractory 63 OncoVEX GM CSF 63 lapatinib 63 Pemetrexed 63 tocilizumab 63 EFAPROXYN 63 Onrigin 63 HRPC 63 indolent NHL 63 azacitidine 63 Pixantrone 63 Taxotere ® 63 sunitinib 63 pomalidomide 63 erlotinib Tarceva ® 63 AP# [003] 63 docetaxel chemotherapy 63 RG# [001] 62 liposomal doxorubicin 62 perifosine 62 relapsed multiple myeloma 62 Pfizer Sutent 62 panitumumab 62 Aplidin 62 Omacetaxine 62 histone deacetylase HDAC inhibitor 62 ponatinib 62 vinorelbine 62 Epratuzumab 62 amrubicin 62 HGS ETR1 62 Bezielle 62 sorafenib 62 iniparib 62 AEG# 62 Doxorubicin 62 Zolinza 62 alkylating agent 62 chemotherapeutic drug 62 Vidaza azacitidine 62 Abraxane 62 Rituxan rituximab 62 Ixempra 62 dacarbazine 62 TORISEL 62 FTY# 62 VAPRISOL 62 nab paclitaxel 62 Erlotinib 62 Amplimexon 62 HER2 positive metastatic breast 62 Insegia 62 OXi# 62 FOLFOX chemotherapy 62 ZOLINZA 62 tesmilifene 62 PLX# 62 refractory chronic lymphocytic 62 PKC# 62 neratinib 62 Erbitux 62 Nexavar sorafenib 62 Bevacizumab 62 Doxil 62 obatoclax 62 capecitabine Xeloda R 62 Panzem R NCD 62 Carfilzomib 62 Bortezomib 61 paclitaxel Taxol 61 Gemzar ® 61 interferon alfa 61 Seliciclib 61 Trastuzumab 61 CHOP chemotherapy 61 FOLFOX6 61 Pirfenidone 61 Dacogen decitabine 61 chemotherapeutic regimen 61 EGFr 61 ofatumumab 61 Tarceva TM 61 Xinlay 61 temozolomide 61 Genasense 61 gemcitabine carboplatin 61 docetaxel Taxotere R 61 TYKERB 61 carboplatin paclitaxel 61 Hycamtin 61 docetaxel Taxotere 61 sunitinib malate 61 sunitinib Sutent 61 Nexavar 61 pralatrexate 61 SCH # 61 PrevOnco 61 MyVax 61 DOXIL 61 estramustine 61 peginterferon 61 HGS ETR2 61 dacetuzumab 61 Sorafenib 61 Davanat 61 oral prodrug 61 BRAF inhibitor 61 fluoropyrimidine 61 Proxinium TM 61 SNT MC# 61 Dacogen injection 61 ELOXATIN 61 gemcitabine Gemzar 61 Cloretazine 61 paclitaxel Taxol ® 61 nilotinib 61 multi kinase inhibitor 61 taxane 61 docetaxel 61 Gliadel Wafer 61 EOquin TM 61 Everolimus 61 #I TM# 61 GSK# [001] 61 Reolysin 61 aflibercept VEGF Trap 61 Amigal 61 TELCYTA 61 thalidomide Thalomid 61 OPAXIO 61 standard chemotherapy regimens 61 Torisel 61 metastatic malignant melanoma 61 JAK inhibitor 61 gefitinib Iressa 61 ganetespib 61 EOquin 61 acyclovir Lauriad R 61 sorafenib Nexavar ® 61 TREANDA 61 Phenoptin 61 IAP inhibitor 61 Chemophase 60 gastrointestinal stromal tumors 60 alvespimycin 60 Folotyn 60 riociguat 60 Romiplostim 60 Herceptin trastuzumab 60 MabCampath 60 GVAX 60 milatuzumab 60 PROMACTA 60 rituximab Rituxan 60 relapsed ovarian cancer 60 tafamidis 60 bortezomib Velcade R 60 erlotinib Tarceva 60 lumiliximab 60 BRIM2 60 Treanda 60 mycophenolate mofetil 60 romidepsin 60 gastrointestinal stromal tumor GIST 60 recurrent NSCLC 60 satraplatin 60 irbesartan 60 Dasatinib 60 Satraplatin 60 Allovectin 7 ® 60 lapatinib Tykerb 60 Pertuzumab 60 Alocrest 60 paclitaxel Taxol R 60 Dacogen 60 KRN# 60 Xanafide 60 Onconase 60 SUTENT 60 SinuNase 60 Blinatumomab 60 subcutaneous formulation 60 lintuzumab 60 Telavancin 60 MAGE A3 ASCI 60 Docetaxel 60 tanespimycin 60 Taxol paclitaxel 60 Panzem 60 tyrosine kinase inhibitor 60 NP2 Enkephalin 60 gastrointestinal stromal tumors GIST 60 R sorafenib tablets 60 anti leukemic 60 thymalfasin 60 cetuximab Erbitux 60 Doxil ® 60 Revlimid 60 Cimzia ® certolizumab pegol 60 ASA# 60 Voreloxin 60 oral Xeloda 60 idarubicin 60 TACE 60 neurologic progression 60 elotuzumab 60 TELINTRA 60 lenalidomide Revlimid R 60 Enzastaurin 60 Quinamed 60 TNF inhibitors 60 pegylated liposomal doxorubicin 60 DAVANAT 60 oral ridaforolimus 60 afatinib 60 daclizumab 60 Cotara 60 Ceflatonin 60 PDX pralatrexate 60 Velcade 60 EGFR expressing mCRC 60 galiximab 60 Mylotarg 60 Pralatrexate 60 PROCHYMAL 60 regorafenib 60 cetuximab 60 Xelox 60 Troxatyl 60 Gleevec imatinib 60 bortezomib Velcade ® 60 PEG SN# 60 dirucotide 60 TEMODAL 60 Vectibix 60 SCCHN 60 adalimumab Humira 60 Metastatic Colorectal Cancer 60 ACTEMRA 60 vinflunine 60 cilengitide 60 Glufosfamide 60 EndoTAGTM 1 60 tezampanel 60 Yervoy 60 basiliximab 60 OMS#HP 60 rNAPc2 60 reslizumab 60 IgG1 monoclonal antibody 60 plus dexamethasone 60 IMC #B 59 metastatic renal cell carcinoma 59 Hodgkin lymphoma NHL 59 FOLFOX4 59 azacytidine 59 bendamustine 59 bevacizumab Avastin ® 59 orBec 59 ara C 59 visilizumab 59 Zarnestra 59 Peg IFN 59 Pegasys ® 59 VEGF Trap 59 refractory AML 59 Ambrisentan 59 Golimumab 59 gemcitabine 59 seliciclib 59 ocular formulation 59 alvimopan 59 Archexin 59 pegylated interferon alfa 59 ELACYT 59 huC# DM4 59 bevacizumab 59 trastuzumab Herceptin 59 XGEVA 59 Aurora kinase 59 Cytoxan 59 Dapagliflozin 59 brain metastases 59 heavily pretreated patients 59 imatinib Gleevec 59 SPRYCEL ® 59 radiolabeled TM# 59 vemurafenib 59 pan HDAC inhibitor 59 mertansine 59 metastatic CRC 59 liposomal formulation 59 ZACTIMA 59 FOLFOX 59 solid tumors 59 mitoxantrone 59 ABRAXANE ® 59 ARIKACE 59 dasatinib Sprycel ® 59 phase IIb clinical 59 metastatic colorectal 59 Tarceva erlotinib 59 Alimta pemetrexed 59 Romidepsin 59 valopicitabine 59 Abatacept 59 taxanes 59 low dose cytarabine 59 PrevOnco ™ 59 posaconazole 59 chemoradiation therapy 59 ZD# [001] 59 eltrombopag 59 oral rivaroxaban 59 talabostat 59 Folfox 59 Camptosar ® 59 hematologic malignancies 59 cangrelor 59 cell lymphoma CTCL 59 RSD# 59 Clofarabine 59 GRN#L 59 Orathecin 59 TTF Therapy 59 Mepact 59 Telcyta 59 Zybrestat 59 Sapacitabine 59 olaparib 59 VIDAZA 59 HuMax CD4 59 pemetrexed Alimta 59 ThermoDox R 59 veltuzumab 59 receptor tyrosine kinase inhibitor 59 Crizotinib 59 PSMA ADC 59 panitumumab Vectibix 59 Increlex ® 59 CIMZIA ™ 59 COPAXONE R 59 targeted radiotherapeutic 59 Campath alemtuzumab 59 forodesine 59 VALSTAR 59 Sym# 59 Corlux 59 ERBITUX 59 leukemia AML 59 TG# [003] 59 Rituximab 59 TRISENOX 59 oral antiviral 59 pemetrexed 59 alfa 2a 59 MyVax R 59 sorafenib Nexavar R 59 BrachySil TM 59 Bronchitol 59 Panzem NCD 59 chemotherapy docetaxel 59 Trabectedin 59 Sprycel 59 anti angiogenic agents 59 chemotherapeutic agent 59 cytotoxic therapy 59 plus DOXIL 59 peg IFN 59 CYT# 59 motesanib 59 ThermoDox ® 59 eniluracil 59 Vidaza 59 Taxotere chemotherapy 59 Pegintron 59 recurrent glioblastoma multiforme 59 refractory multiple myeloma 59 Peginterferon alfa 2b 59 MNTX 59 Erbitux cetuximab 59 custirsen 59 Eculizumab 59 Azixa 59 metastatic castration resistant 59 ACTEMRA TM 59 Platinol ® 58 5 FU 58 pegylated interferon 58 Combidex 58 metastatic HRPC 58 lymphoid malignancies 58 IMGN# 58 Targretin capsules 58 MOZOBIL 58 infusional 5-FU/LV 58 Navelbine ® 58 Actemra 58 AGILECT R 58 OHR/AVR# 58 TAXOTERE R 58 MYDICAR ® 58 B CLL 58 recurrent glioblastoma 58 5-FU/LV 58 Pivotal Phase III 58 #D#C# 58 TYZEKA 58 Cetuximab 58 EGFR expressing 58 cyclophosphamide chemotherapy 58 OMP #M# 58 Allovectin 7 R 58 aprepitant 58 VELCADE 58 fluorouracil 58 GEM OS1 58 picoplatin 58 tubulin inhibitor 58 cyclophosphamide Cytoxan 58 anti TNF 58 tipifarnib 58 Pixuvri 58 Tamibarotene 58 Taxotere docetaxel 58 Fodosine 58 PegIntron 58 Tarceva 58 LAF# 58 cabazitaxel 58 GRN# 58 hormone refractory prostate cancer 58 Vaprisol 58 biologic therapy 58 vidofludimus 58 Vorinostat 58 IL# PE#QQR 58 Taxotere R 58 febuxostat 58 Gleevec imatinib mesylate 58 phase Ib 58 CD# antibody [001] 58 Xcytrin R 58 DFMO 58 chlorambucil 58 ATL# [001] 58 VNP#M 58 cetuximab Erbitux R 58 overlapping toxicities 58 doxorubicin HCl liposome injection 58 gadobutrol 58 cisplatin chemotherapy 58 lesinurad 58 Denufosol 58 CIMZIA TM certolizumab pegol 58 FOLPI 58 anti angiogenic agent 58 irinotecan chemotherapy 58 Catena ® 58 efalizumab 58 Aliskiren 58 Tasigna nilotinib 58 Lapatinib 58 refractory indolent non 58 Cutaneous T 58 Tyrima 58 Fludara ® 58 HuMax CD# 58 imatinib therapy 58 5FU 58 denileukin diftitox 58 alefacept 58 relapsed MM 58 Phase Ib 58 Onco TCS 58 DAVANAT R 58 L MTP PE 58 CBLC# 58 EndoTAG TM -1 58 Sutent 58 esophageal candidiasis 58 Topotecan 58 Lacosamide 58 Lenocta 58 monotherapy 58 immunomodulator 58 etanercept 58 AEGR 58 Omnitarg 58 chronic lymphocytic leukemia CLL 58 Azathioprine 58 HDAC Inhibitor 58 adecatumumab 58 fallopian tube cancers 58 FOLOTYN 58 OZURDEX ® 58 Cloretazine R VNP#M 58 Vitrase 58 Capecitabine 58 CYT# potent vascular disrupting 58 Sutent sunitinib 58 crizotinib PF # 58 dose cohorts 58 Zevalin R Ibritumomab 58 systemic ALCL 58 YONDELIS R 58 INCB# [002] 58 malignant ascites 58 Phase Ib study 58 nucleotide analogue 58 sapacitabine 58 refractory Hodgkin lymphoma 58 tipranavir 58 AQ4N 58 TNFerade 58 ipilimumab 58 Mitoxantrone 58 Alemtuzumab 58 radiation sensitizer 58 Fibrillex TM 58 NXL# 58 INC# 58 DORIBAX 58 multiple myeloma MM 58 Lenalidomide 58 Darusentan 58 vascular disrupting agent 58 fibrinolytic 58 hematological malignancies 58 Neulasta ® 58 Junovan 58 Xcellerated T Cells 58 Fludarabine 58 Ocrelizumab 58 Promacta 58 COPAXONE ® 58 plus prednisone 58 octreotide 58 Methylnaltrexone 58 irinotecan 58 fludarabine 58 cutaneous T cell 58 Boceprevir 58 Phase 1b 58 chemotherapeutic agents 58 voreloxin 58 ASONEP 58 XL# [003] 58 Alimta 58 VEGF receptor inhibitor 58 Aptivus ® 58 ZK EPO 58 leukemia CLL 58 elagolix 58 TLK# 58 baminercept 58 abiraterone 58 REOLYSIN ® 58 Trexima 58 Hycamtin ® 58 AVOREN 58 proteasome inhibitor 58 PNP inhibitor 58 Icatibant 57 YERVOY 57 antibody MAb 57 refractory CTCL 57 evaluating Xcytrin 57 brentuximab vedotin 57 Paraplatin ® 57 concurrent chemoradiation 57 IRX 2 57 dasatinib Sprycel 57 ONGLYZA ™ 57 TNF inhibitor 57 Removab 57 active comparator 57 Vitaxin 57 AVASTIN 57 synthetic retinoid 57 LY# [003] 57 LEUKINE 57 Talabostat 57 GALNS 57 ON #.Na 57 metastatic colorectal cancer 57 Neurodex 57 BrachySil 57 APTIVUS r 57 Soliris TM eculizumab 57 mTOR inhibitors 57 XELOX 57 IMA# 57 anti EGFR antibody 57 melphalan 57 calcineurin inhibitor 57 pegylated interferon alpha 57 mRCC 57 DASISION 57 follicular NHL 57 bosutinib 57 Zalbin 57 Civacir 57 Allovectin 7 57 NOXAFIL 57 Linaclotide 57 atrasentan 57 AeroLEF TM 57 somatostatin analogues 57 pseudobulbar affect PBA 57 Lilly Gemzar 57 TRV# [001] 57 HSP# inhibitor 57 chronic angina 57 Melphalan 57 Complete Response 57 Mipomersen 57 interferon gamma 1b 57 CANCIDAS 57 proteasome inhibitor bortezomib 57 Pegylated Interferon 57 PEG Interferon lambda 57 EGFR TKI 57 #ME# 57 bortezomib Velcade 57 ImClone Erbitux 57 Virulizin R 57 Actilon 57 Gleevec resistant 57 Aclidinium 57 Evoltra TM 57 AZT zidovudine Retrovir 57 HuLuc# 57 Firazyr 57 Nanobody 57 TriRima 57 PS# [001] 57 colorectal cancer liver metastases 57 Noxafil 57 Eribulin 57 Rituxan 57 angiogenesis inhibitor 57 telaprevir 57 HDACi 57 melphalan prednisone 57 alemtuzumab Campath 57 molecularly targeted 57 Phase 2a trial 57 INCB# [001] 57 humanized antibody 57 Orphan Drug Status 57 LymphoStat B belimumab 57 investigational humanized monoclonal antibody 57 Afatinib 57 Oxaliplatin 57 SIR Spheres 57 superficial bladder cancer 57 deforolimus 57 TAFA# 57 Revlimid lenalidomide 57 CINTREDEKIN BESUDOTOX 57 hormone LHRH antagonist 57 tamibarotene 57 ReoPro 57 microtubule inhibitor 57 fenofibric acid 57 IAP inhibitors 57 microtubule targeting 57 Exherin TM 57 Clolar 57 brivaracetam 57 plus methotrexate 57 5 FU leucovorin 57 Teriflunomide 57 temsirolimus Torisel ® 57 Abiraterone acetate 57 advanced metastatic renal 57 clodronate 57 Elotuzumab 57 ISTODAX 57 teduglutide 57 teriflunomide 57 Afinitor 57 REVLIMID 57 PD LID 57 Daclizumab 57 metastatic kidney 57 RoACTEMRA 57 neuroendocrine tumors 57 Vasovist 57 Azacitidine 57 FOLFIRINOX 57 bleomycin 57 non metastatic osteosarcoma 57 Phase Ib II 57 CEQ# 57 ongoing Phase 1b 57 LEP ETU 57 interferon alfa 2b 57 amphotericin B 57 lymphoma CTCL 57 metastatic colon cancer 57 rilonacept 57 BEACOPP 57 rituximab 57 Telaprevir 57 EVIZON 57 doripenem 57 Sudhir Agrawal D.Phil 57 pazopanib 57 ThermoDox 57 EGFR inhibitors 57 XmAb# 57 OMP #R# 57 refractory acute myeloid 57 AZD# 57 eribulin mesylate 57 Mozobil 57 bicalutamide 57 Symadex 57 rindopepimut 57 relapsed leukemia 57 favorable pharmacokinetic profile 57 Taxotere 57 Rexin G 57 Ixabepilone 57 LIALDA 57 capecitabine Xeloda 57 NLX P# 57 Arcalyst 57 belinostat 57 pegfilgrastim 57 Copegus ribavirin 57 Diovan HCT 57 Revimmune 57 Ozarelix 57 Etanercept 57 elacytarabine 57 Tekamlo 57 Fulvestrant 57 mCRC patients 57 albinterferon alfa 2b 57 Annamycin 57 PI3K/Akt pathway inhibitor 57 icatibant 57 GEM OS2 57 iloprost 57 palifosfamide 57 lenalidomide dexamethasone 57 Clevudine 57 Genasense ® 57 surrogate endpoint 57 OncoVEX 57 DMARD 57 tyrosine kinase inhibitors 57 Panzem R 57 follicular lymphoma FL 57 abatacept 57 Vinorelbine 57 adalimumab 57 proteasome inhibitors 57 chemoradiation 57 MabThera Rituxan 57 imetelstat 57 plus ribavirin 57 5 Fluorouracil 57 plus prednisone prednisolone 57 investigational monoclonal antibody 57 Diabetic Macular Edema 57 Pazopanib 57 oral deforolimus 57 ULORIC 57 immunomodulatory 57 RAD# [003] 57 anidulafungin 57 Prochymal 57 Ontak 57 anthracycline taxane 57 oxaliplatin 57 vernakalant hydrochloride 57 APOPTONE 57 Dupuytren Contracture 57 imatinib Gleevec ® 57 Tesetaxel 57 Cremophor 57 Infliximab 57 GW# [003] 57 telaprevir dosed 57 evaluating tivozanib 57 entecavir 57 PIX# [002] 57 LymphoStat B TM 57 cancer immunotherapies 57 chronic myeloid leukemia CML 57 Cellegesic 57 imatinib mesylate Gleevec 57 virus HCV protease inhibitor 57 mg kg dose 57 ularitide 57 SomatoKine 57 neoadjuvant treatment 57 Marketing Authorization Application 57 antitumor activity 57 imatinib resistant 56 IMiDs 56 docetaxel prednisone 56 Lubiprostone 56 ruxolitinib 56 Carboplatin 56 viral kinetics 56 paclitaxel poliglumex 56 5 fluorouracil 56 Durezol 56 ADVANCE PD 56 alemtuzumab 56 cancer mCRC 56 Northera 56 Myelofibrosis 56 plus gemcitabine 56 carcinoma HCC 56 PRT# 56 Zenvia Phase III 56 Diffuse Large B 56 GAMMAGARD 56 paclitaxel chemotherapy 56 Evicel 56 prGCD 56 Panitumumab 56 Roche Xeloda 56 relapsed refractory 56 dose escalation 56 refractory NSCLC 56 Alpharadin 56 ALKS 56 leucovorin 56 chemoradiotherapy 56 Sandostatin LAR 56 voclosporin 56 XYOTAX TM 56 histologies 56 G#DT 56 Temozolomide 56 interferon therapy 56 sipuleucel T 56 Kynapid 56 NVA# 56 ELND# 56 castration resistant prostate cancer 56 Pimavanserin 56 radiofrequency ablation RFA 56 pentostatin 56 AA amyloidosis 56 Gabapentin GR 56 Xeloda capecitabine 56 unresectable 56 Darinaparsin 56 calcineurin inhibitors 56 Fluorouracil 56 uric acid lowering 56 lupus nephritis 56 CYC# 56 MKC# PP 56 ONCONASE 56 recurrent glioma 56 Tykerb 56 Emend 56 Apaziquone 56 Degarelix 56 zileuton 56 Teysuno 56 FOLFIRI chemotherapy 56 eculizumab 56 pain palliation 56 Delcath PHP System 56 Tocosol Paclitaxel 56 trodusquemine 56 abatacept Orencia 56 anticancer agent 56 FOLOTYN ® 56 Rebif ® 56 Atiprimod 56 ALK inhibitor 56 Phase #/#a trial 56 Zenvia 56 maribavir 56 Cisplatin 56 signal transduction inhibitor 56 CAELYX 56 Tarvacin 56 hormone refractory metastatic prostate 56 xanthine oxidase inhibitor 56 dirucotide MBP# 56 Lialda 56 Platinol 56 Evoltra 56 UPLYSO 56 rituximab Rituxan ® 56 Dual Opioid 56 mitomycin 56 ONCASPAR 56 gefitinib 56 TNF antagonist 56 HGS ETR1 mapatumumab 56 erlotinib 56 nucleoside analog 56 Actemra tocilizumab 56 cisplatin gemcitabine 56 systemic anaplastic large 56 metastatic GIST 56 TroVax ® 56 eritoran 56 APTIVUS R 56 paliperidone ER 56 selective androgen receptor modulator 56 Tanespimycin 56 trastuzumab Herceptin R 56 EP #R 56 small molecule tyrosine 56 romiplostim 56 Vidofludimus 56 NSCLC 56 regadenoson 56 selective modulator 56 gemcitabine cisplatin 56 T#I [002] 56 IIa trial 56 SinuNase TM 56 FUSILEV enhances 56 registrational 56 PEGylated 56 Torisel temsirolimus 56 8mg/kg 56 BMS # 56 relapsed myeloma 56 talactoferrin